August 26, 2015
2 min read
Save

Various IOP measurements appropriate for monitoring children

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Rebound, noncontact and Goldmann applanation tonometries demonstrated similar results when measuring intraocular pressure in children, according to a study recently published in the American Journal of Ophthalmology.

Perspective from Blair Lonsberry, OD, FAAO

Feng and colleagues conducted a diagnostic protocol comparison and evaluation to assess the various methods.

Researchers evaluated IOP measurements from the right eyes of 419 children between the ages of 3 and 15 years old. IOP was measured by rebound tonometer (ICare PRO, ICare), noncontact tonometer (Topcon CT80, Topcon) and Goldmann applanation tonometer (Haag-Streit AG).

Results showed that the mean IOP obtained by rebound tonometry was 16.87 ± 3.06 mm Hg, by noncontact tonometry was 17.69 ± 2.44 mm Hg and by GAT was 15.21 ± 2.06 mm Hg.

"IOP readings obtained with the three tonometries evaluated in this study showed a reasonable concordance with each other, and all of them can be considered appropriate methods for routine clinical use," the authors concluded. "Because the rebound and noncontact tonometries can be used without an anesthetic, either of them can be a positive alternative for comfortable, high-success-rate measurement of child IOP."

The researchers suggested that eye care providers pay specific attention to children with thicker central corneas or with IOPs within a suspicious range because of the possibility of overestimation.

They wrote: "In light of this risk of false-positive diagnosis of pediatric glaucoma, patients with high IOP readings should be retested by other methods, including GAT." – by Chelsea Frajerman Pardes

Disclosure: The authors report no relevant financial disclosures.